Wei Chuen TAN-KOI 个人学术档案

引用次数

	总计	2019 年至今
引用	205	147
h 指数	7	7
i10 指数	7	6

2016201720182019202020212022202320244 28 21 24 30 31 29 18 15

合著作者

Teo Yik YingAssociate Professor, Saw Swee Hock School of Public Health, National University of Singapore在 nuhs.edu.sg 的电子邮件经过验证
Cynthia Sung, PhD FCPGates Medical Research Institute; Health Sciences Authority Singapore; Duke-NUS;在 duke-nus.edu.sg 的电子邮件经过验证
Ritika KapoorAstellas Pharma在 astellas.com 的电子邮件经过验证
Eric FinkelsteinProfessor of Health Services and Systems Research, Duke-NUS Medical School, Singapore在 duke-nus.edu.sg 的电子邮件经过验证
Chuenjid Kongkaew or Chuenjid Kong...Naresuan University; The University of Manchester; University College of London在 nu.ac.th 的电子邮件经过验证
Teerapon DhippayomAssociate Professor, Naresuan University在 nu.ac.th 的电子邮件经过验证
lee haur yuehSingapore General Hospital, Department of Dermatology在 singhealth.com.sg 的电子邮件经过验证
Yen Loo LimNational Skin Centre在 nsc.com.sg 的电子邮件经过验证
Ee Chee RENSenior Principal Investigator, Singapore Immunology Network在 immunol.a-star.edu.sg 的电子邮件经过验证
chen wee aw derrickAssociate Professor在 singhealth.com.sg 的电子邮件经过验证
yiwei pan在 singhealth.com.sg 的电子邮件经过验证
Kevin LimPaediatric Orthopaedic & Spine Surgeon在 singhealth.com.sg 的电子邮件经过验证
William HwangMedical Director, National Cancer Centre Singapore在 singhealth.com.sg 的电子邮件经过验证
Yoong Khean KhooDuke-NUS Medical School在 duke-nus.edu.sg 的电子邮件经过验证
Di DongWorld Bank Group
Natalie TanSenior Consultant, Infectious Disease Service,Department of Paediatrics,KK Women's & Children's在 singhealth.com.sg 的电子邮件经过验证
Edmund Lee Jon DeoonNational University of Singapore

关注

Wei Chuen TAN-KOI

Assistant Professor, Centre of Regulatory Excellence, Duke-NUS Medical School

在 duke-nus.edu.sg 的电子邮件经过验证

Health Policy and Regulation Vaccine Regulation Pharmacovigilance Pharmacogenomics


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Cost–Effectiveness Analysis of Genotyping for HLA-B5801* and an Enhanced Safety Program in Gout Patients Starting Allopurinol in Singapore D Dong, WC Tan-Koi, GG Teng, E Finkelstein, C Sung Pharmacogenomics 16 (16), 1781-1793, 2015	46	2015
Role of pharmacogenetics in public health and clinical health care: a SWOT analysis R Kapoor, WC Tan-Koi, YY Teo European Journal of Human Genetics 24 (12), 1651-1657, 2016	44	2016
Pharmacovigilance activities in ASEAN countries W Suwankesawong, T Dhippayom, WC Tan‐Koi, C Kongkaew pharmacoepidemiology and drug safety 25 (9), 1061-1069, 2016	30	2016
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach WC Tan-Koi, C Sung, YY Chong, A Lateef, SM Pang, A Vasudevan, D Aw, ... Pharmacogenomics 18 (9), 881-890, 2017	19	2017
Applications of pharmacogenomics in regulatory science: a product life cycle review WC Tan-Koi, PC Leow, YY Teo The pharmacogenomics journal 18 (3), 359-366, 2018	17	2018
Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment WC Tan-Koi, ESH Lim, YY Teo The pharmacogenomics journal 17 (2), 121-127, 2017	13	2017
Post-vaccination abscesses requiring surgical drainage in a tertiary children’s hospital in Singapore NWH Tan, WJ Pan, HHBM Yunos, WC Tan, KBL Lim Journal of Pediatric Infectious Diseases 5 (02), 139-147, 2010	12	2010
Is HLA-B* 58: 01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease? GG Teng, WC Tan-Koi, D Dong, C Sung Pharmacogenomics 21 (4), 279-291, 2020	7	2020
The importance of ethnicity definitions and pharmacogenomics in ethnobridging and pharmacovigilance WC Tan-Koi, M Limenta, EHM Mohamed, EJD Lee Pharmacogenomics, 289-327, 2019	7	2019
A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB112:02* CW Tan, WC Tan-Koi, J Ng, CM Chan, WYK Hwang Pharmacogenomics 17 (11), 1235-1243, 2016	7	2016
Pharmacogenetics through a public health lens: from policy to practice WC Tan-Koi, R Kapoor, YY Teo Pharmacogenetics and Genomics 25 (10), 518-520, 2015	3	2015
Regulation in the age of calamity: Changing the regulatory paradigm R Hatchett, MXJ Chan, A Hacker, WC Tan‐Koi, S Vogel, JCW Lim Clinical and Translational Science 17 (7), e13882, 2024		2024
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making YK Khoo, JCW Lim, WC Tan-Koi, NS Kitikiti, AL Sim-Devadas Drug Safety 47 (3), 217-225, 2024		2024
PANDEMIC VACCINE DEVELOPMENT QR Yap, WC Tan-Koi, JCW Lim, EE Ooi

系统目前无法执行此操作，请稍后再试。

文章 1–14

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用